Search research articles
Contact Us
Filters
Showing results (1-10 of 86) with videos related to
Page
of 9
Sort By:
Current Opinion in Pharmacology
|
April 9, 2019
The role of the P2X7 receptor in myeloid-derived suppressor cells and immunosuppression
Elisa Principi, Lizzia Raffaghello
Expert Review of Clinical Immunology
|
April 21, 2010
Potential of mesenchymal stem cells for the therapy of autoimmune diseases
Vito Pistoia, Lizzia Raffaghello
International Immunology
|
March 25, 2017
Mesenchymal stromal cells and autoimmunity
Vito Pistoia, Lizzia Raffaghello
Expert Review of Neurotherapeutics
|
April 21, 2006
Immunotherapy of neuroblastoma: present, past and future
Lizzia Raffaghello, Vito Pistoia
European Journal of Immunology
|
January 18, 2014
Unveiling the role of TNF-α in mesenchymal stromal cell-mediated immunosuppression
Vito Pistoia, Lizzia Raffaghello
Immunology Letters
|
July 7, 2015
Classification and biology of tumour associated stromal cells
Lizzia Raffaghello, Francesco Dazzi
European Journal of Immunology
|
June 28, 2011
Damage-associated molecular patterns (DAMPs) and mesenchymal stem cells: a matter of attraction and excitement
Vito Pistoia, Lizzia Raffaghello
Current Pharmaceutical Biotechnology
|
April 8, 2011
Immunosuppressive treatments in acute myocardial infarction and stroke
Lizzia Raffaghello, Giovanna Bianchi, Vito Pistoia
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
March 7, 2012
Starvation, detoxification, and multidrug resistance in cancer therapy
Changhan Lee, Lizzia Raffaghello, Valter D Longo
Oncotarget
|
December 5, 2014
Cancer associated fibroblasts in hematological malignancies
Lizzia Raffaghello, Angelo Vacca, Vito Pistoia, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 86) with videos related to
Sort By:
Page
of 9
Current Opinion in Pharmacology
|
April 9, 2019
The role of the P2X7 receptor in myeloid-derived suppressor cells and immunosuppression
Elisa Principi, Lizzia Raffaghello
Expert Review of Clinical Immunology
|
April 21, 2010
Potential of mesenchymal stem cells for the therapy of autoimmune diseases
Vito Pistoia, Lizzia Raffaghello
International Immunology
|
March 25, 2017
Mesenchymal stromal cells and autoimmunity
Vito Pistoia, Lizzia Raffaghello
Expert Review of Neurotherapeutics
|
April 21, 2006
Immunotherapy of neuroblastoma: present, past and future
Lizzia Raffaghello, Vito Pistoia
European Journal of Immunology
|
January 18, 2014
Unveiling the role of TNF-α in mesenchymal stromal cell-mediated immunosuppression
Vito Pistoia, Lizzia Raffaghello
Immunology Letters
|
July 7, 2015
Classification and biology of tumour associated stromal cells
Lizzia Raffaghello, Francesco Dazzi
European Journal of Immunology
|
June 28, 2011
Damage-associated molecular patterns (DAMPs) and mesenchymal stem cells: a matter of attraction and excitement
Vito Pistoia, Lizzia Raffaghello
Current Pharmaceutical Biotechnology
|
April 8, 2011
Immunosuppressive treatments in acute myocardial infarction and stroke
Lizzia Raffaghello, Giovanna Bianchi, Vito Pistoia
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
March 7, 2012
Starvation, detoxification, and multidrug resistance in cancer therapy
Changhan Lee, Lizzia Raffaghello, Valter D Longo
Oncotarget
|
December 5, 2014
Cancer associated fibroblasts in hematological malignancies
Lizzia Raffaghello, Angelo Vacca, Vito Pistoia, et al.
Page
of 9